Qube Research & Technologies (QRT)’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.9K Buy
15,570
+391
+3% +$825 ﹤0.01% 2423
2025
Q1
$18.5K Buy
15,179
+3,049
+25% +$3.72K ﹤0.01% 2479
2024
Q4
$15.6K Buy
+12,130
New +$15.6K ﹤0.01% 2453
2024
Q2
Sell
-69,045
Closed -$165K 3668
2024
Q1
$165K Sell
69,045
-6,367
-8% -$15.2K ﹤0.01% 2646
2023
Q4
$125K Buy
75,412
+71,790
+1,982% +$119K ﹤0.01% 2616
2023
Q3
$6.95K Buy
+3,622
New +$6.95K ﹤0.01% 2952